PepDialed

Reference · cited facts

Peptide reference & calculators

Each peptide has a neutral, cited reference page and a reconstitution calculator that runs pure math on the values you enter. We recommend no doses.

Educational information and a math tool only — not medical advice, a dose recommendation, or an endorsement of peptide use. Not FDA-approved for human use. Consult a licensed healthcare provider before starting, stopping, or changing anything.

RetatrutideLY3437943
Research use

HALF-LIFE ≈6 DAYS · VIALS 5/10/20/30 MG · LIMITED HUMAN DATA

Research use

HALF-LIFE NO ESTABLISHED HUMAN HALF-LIFE · VIALS 2/5/10 MG · LIMITED (LARGELY NEGATIVE HUMAN TRIALS)

Research use

HALF-LIFE UNCHARACTERIZED IN HUMANS · VIALS 5/10 MG · PRECLINICAL ONLY

TirzepatideMounjaro / Zepbound
FDA-approved

HALF-LIFE ≈5 DAYS · VIALS 10/20/30/40 MG · ESTABLISHED (FDA-APPROVED)

SemaglutideOzempic / Wegovy / Rybelsus
FDA-approved

HALF-LIFE ≈7 DAYS · VIALS 2/4/8 MG · ESTABLISHED (FDA-APPROVED)

BPC-157Body Protection Compound-157
Research use

HALF-LIFE NO ESTABLISHED HUMAN HALF-LIFE · VIALS 5/10 MG · PRECLINICAL ONLY

SermorelinGHRH(1-29) / GRF 1-29 / Geref
FDA-approved

HALF-LIFE ≈11–12 MINUTES · VIALS 2/5 MG · ESTABLISHED (FDA-APPROVED)

Thymosin Alpha-1Thymalfasin / Zadaxin / Tα1
Research use

HALF-LIFE ≈2 HOURS · VIALS 1.6/5/10 MG · LIMITED HUMAN DATA

PT-141Bremelanotide / Vyleesi
FDA-approved

HALF-LIFE ≈11 HOURS · VIALS 10 MG · ESTABLISHED (FDA-APPROVED)

TesamorelinEgrifta / Egrifta SV / GHRH analog
FDA-approved

HALF-LIFE ≈26–38 MINUTES (SHORT) · VIALS 2/5/10 MG · ESTABLISHED (FDA-APPROVED)

LiraglutideVictoza / Saxenda
FDA-approved

HALF-LIFE ≈13 HOURS · VIALS 5/10 MG · ESTABLISHED (FDA-APPROVED)